Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Authors
Keywords
-
Journal
LEUKEMIA
Volume 27, Issue 4, Pages 780-791
Publisher
Springer Nature
Online
2012-11-21
DOI
10.1038/leu.2012.336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- How I treat plasma cell leukemia
- (2012) N. W. C. J. van de Donk et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols
- (2012) S Z Usmani et al. LEUKEMIA
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
- (2011) L. Pagano et al. ANNALS OF ONCOLOGY
- Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party
- (2011) G. D'Arena et al. ANNALS OF ONCOLOGY
- Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
- (2011) N. C. Munshi et al. BLOOD
- Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
- (2011) M. Dimopoulos et al. BLOOD
- Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
- (2011) Daniel Lebovic et al. Clinical Lymphoma Myeloma & Leukemia
- Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
- (2011) A Mahindra et al. LEUKEMIA
- Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen
- (2010) Edward Libby et al. AMERICAN JOURNAL OF HEMATOLOGY
- CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group
- (2010) Matthew Walters et al. BRITISH JOURNAL OF HAEMATOLOGY
- Primary plasma cell leukemia and autologous stem cell transplantation
- (2010) M. B. Drake et al. HAEMATOLOGICA
- Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia
- (2010) Maria Kraj et al. LEUKEMIA RESEARCH
- A Retrospective Analysis of Thirty-One Cases of Plasma Cell Leukemia from a Single Center in China
- (2009) Qi Peijing et al. ACTA HAEMATOLOGICA
- Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy
- (2009) Jennifer Pretz et al. AMERICAN JOURNAL OF HEMATOLOGY
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Primary plasma cell leukemia
- (2009) Giridharan Ramsingh et al. CANCER
- Differential repetitive DNA methylation in multiple myeloma molecular subgroups
- (2009) V. Bollati et al. CARCINOGENESIS
- Frequent upregulation ofMYCin plasma cell leukemia
- (2009) Laura Chiecchio et al. GENES CHROMOSOMES & CANCER
- Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: A case report
- (2009) Attilio Olivieri et al. LEUKEMIA RESEARCH
- Lenalidomide, Melphalan, and Prednisone Association Is an Effective Salvage Therapy in Relapsed Plasma Cell Leukaemia
- (2009) Tommasina Guglielmelli et al. Journal of Oncology
- Genetic aberrations and survival in plasma cell leukemia
- (2008) R E Tiedemann et al. LEUKEMIA
- Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy
- (2008) Chadi Al-Nawakil et al. LEUKEMIA & LYMPHOMA
- Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia
- (2008) Pellegrino Musto et al. LEUKEMIA RESEARCH
- Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
- (2008) Eirini Katodritou et al. LEUKEMIA RESEARCH
- Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia
- (2008) Hong Chang et al. LEUKEMIA RESEARCH
- Thalidomide treatment down-regulates SDF-1α and CXCR4 expression in multiple myeloma patients
- (2008) Adriana Morgan Oliveira et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started